Skip to main content
Clinical Trials/EUCTR2012-004770-25-IT
EUCTR2012-004770-25-ITActive, not recruitingNot Applicable

CLOpidogrel versus TIcagreLor for antiplatelet maintenance in DIAbetic patients (CLOTILDIA) - CLOTILDIA

IVERSITA' CAMPUS BIOMEDICO0 sitesStarted: December 11, 2012Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • patients with type 2 diabetes mellitus (oral antidiabetic drugs) and known coronary artery disease on dual antiplatelet therapy (aspirin 100 mg qd and clopidogrel 75 mg qd)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 54

Exclusion Criteria

  • 1. Patients with platelet counts less than 70 × 109 / L
  • 2. Patients undergoing surgery for coronary artery bypass grafting in the previous three months
  • 3. Patients with a recent episode of major bleeding (<6 months)
  • 4. Patients with chronic renal failure, severe (GFR <30 ml / min)
  • 5. Patients with severe left ventricular dysfunction (ejection fraction <30%)

Investigators

Sponsor
IVERSITA' CAMPUS BIOMEDICO

Similar Trials

CLOpidogrel versus TIcagreLor for... | Clinical Trial